Foundation Medicine
@foundationmedicine.bsky.social
Foundation Medicine a precision medicine company transforming lives in cancer and beyond.
Community Guidelines: http://bit.ly/3iSL4jW
Community Guidelines: http://bit.ly/3iSL4jW
At #ESMOAsia25, Foundation Medicine is excited to join industry peers from across the Asia-Pacific region to discuss the latest research & innovations happening in oncology. Visit Foundation Medicine at booth B111, hall 4 to meet with our team. Learn more: spkl.io/63327AeniJ
November 25, 2025 at 9:00 PM
At #ESMOAsia25, Foundation Medicine is excited to join industry peers from across the Asia-Pacific region to discuss the latest research & innovations happening in oncology. Visit Foundation Medicine at booth B111, hall 4 to meet with our team. Learn more: spkl.io/63327AeniJ
#NewResearch – “Intratumoral heterogeneity and immunotherapy resistance: clinical implications” Read more: spkl.io/63320AencI
November 25, 2025 at 1:00 PM
#NewResearch – “Intratumoral heterogeneity and immunotherapy resistance: clinical implications” Read more: spkl.io/63320AencI
A recently published investigator-initiated study utilized Foundation Medicine’s tissue- and blood-based comprehensive genomic profiling to identify actionable alterations: “Genomically matched therapy in advanced solid tumors: the randomized phase 2 ROME trial” in @natmed.nature.com
November 14, 2025 at 3:05 PM
A recently published investigator-initiated study utilized Foundation Medicine’s tissue- and blood-based comprehensive genomic profiling to identify actionable alterations: “Genomically matched therapy in advanced solid tumors: the randomized phase 2 ROME trial” in @natmed.nature.com
We are proud to support @lungevity.bsky.social's Cancer Precision Medicine Commons to further raise awareness and education around biomarker testing this #CancerBiomarkerDay. Click here for more information and resources: spkl.io/63321Abxmz
November 13, 2025 at 1:00 PM
We are proud to support @lungevity.bsky.social's Cancer Precision Medicine Commons to further raise awareness and education around biomarker testing this #CancerBiomarkerDay. Click here for more information and resources: spkl.io/63321Abxmz
Our latest webinar with @precmedonline.bsky.social will focus on the evolving landscape of biomarker-genomic treatment for advanced non-small cell #lungcancer (NSCLC). Join us for this expert-led conversation – register today: spkl.io/63320AwAb2
November 7, 2025 at 1:00 PM
Our latest webinar with @precmedonline.bsky.social will focus on the evolving landscape of biomarker-genomic treatment for advanced non-small cell #lungcancer (NSCLC). Join us for this expert-led conversation – register today: spkl.io/63320AwAb2
#NewResearch published in Cancer Research Communications: “Succinate dehydrogenase B (SDHB) overexpression with enzymatic dysfunction defines a distinct subtype of undifferentiated pleomorphic sarcoma.” Click to learn more: spkl.io/63327AwdBx
November 4, 2025 at 6:00 PM
#NewResearch published in Cancer Research Communications: “Succinate dehydrogenase B (SDHB) overexpression with enzymatic dysfunction defines a distinct subtype of undifferentiated pleomorphic sarcoma.” Click to learn more: spkl.io/63327AwdBx
Foundation Medicine will be at #AMPath25 at booth 320! Schedule time to explore solutions that help deliver deeper #genomic insights and more actionable results: spkl.io/63321AwwxT
November 4, 2025 at 3:30 PM
Foundation Medicine will be at #AMPath25 at booth 320! Schedule time to explore solutions that help deliver deeper #genomic insights and more actionable results: spkl.io/63321AwwxT
Honoring #LungCancer Awareness Month this November and all those within our community and beyond who have been impacted by the disease. Follow us this month for patient stories, resources and more.
November 3, 2025 at 2:00 PM
Honoring #LungCancer Awareness Month this November and all those within our community and beyond who have been impacted by the disease. Follow us this month for patient stories, resources and more.
We’re proud to collaborate with Manifold, the AI data platform for life sciences, to bring enhanced analytics capabilities to our FoundationInsights® platform. Learn more: www.foundationmedicine.com/press-releas...
October 30, 2025 at 11:07 AM
We’re proud to collaborate with Manifold, the AI data platform for life sciences, to bring enhanced analytics capabilities to our FoundationInsights® platform. Learn more: www.foundationmedicine.com/press-releas...
Join us at #ISLB25 – November 1-3. Meet our team at booth 201 to learn more about how Foundation Medicine and our FDA-approved #LiquidBiopsy test provides information that can help physicians determine treatment paths for their patients with advanced cancer.
October 23, 2025 at 4:33 PM
Join us at #ISLB25 – November 1-3. Meet our team at booth 201 to learn more about how Foundation Medicine and our FDA-approved #LiquidBiopsy test provides information that can help physicians determine treatment paths for their patients with advanced cancer.
Hear from experts through a series of webinars on the importance of biomarker testing, specifically comprehensive genomic profiling, in #BreastCancer treatment and care. Explore our “Pioneers in Practice – Breast Series” at the link here: spkl.io/63323AXq8Z
Pioneers in Practice - Breast Series
Share your videos with friends, family, and the world
spkl.io
October 22, 2025 at 4:00 PM
Hear from experts through a series of webinars on the importance of biomarker testing, specifically comprehensive genomic profiling, in #BreastCancer treatment and care. Explore our “Pioneers in Practice – Breast Series” at the link here: spkl.io/63323AXq8Z
#NewResearch publication in @natgenet.nature.com – “Meta-analysis reveals differences in somatic alterations by genetic ancestry across common cancers.” Learn more: spkl.io/63324AXoYY
October 20, 2025 at 5:34 PM
#NewResearch publication in @natgenet.nature.com – “Meta-analysis reveals differences in somatic alterations by genetic ancestry across common cancers.” Learn more: spkl.io/63324AXoYY
#NewResearch being presented at #ESMO25 features data utilizing Foundation Medicine’s tissue-based RNA sequencing test in #BreastCancer. Visit us at booth 3028 in Hall 3.2! Discover more and connect with our team at this year’s meeting: spkl.io/63321AXB0f
October 19, 2025 at 1:00 PM
#NewResearch being presented at #ESMO25 features data utilizing Foundation Medicine’s tissue-based RNA sequencing test in #BreastCancer. Visit us at booth 3028 in Hall 3.2! Discover more and connect with our team at this year’s meeting: spkl.io/63321AXB0f
#ESMO25 research - data leveraged the research use version of Foundation Medicine's tissue-free treatment response monitoring assay: “Circulating tumor DNA dynamics correlate with response to carboplatin with or without nivolumab in metastatic TNBC" spkl.io/63329AXBLl
October 18, 2025 at 1:00 PM
#ESMO25 research - data leveraged the research use version of Foundation Medicine's tissue-free treatment response monitoring assay: “Circulating tumor DNA dynamics correlate with response to carboplatin with or without nivolumab in metastatic TNBC" spkl.io/63329AXBLl
Explore the latest in research involving Foundation Medicine’s homologous recombination deficiency signature (HRDsig) across key disease areas, including ovarian, lung & gastric cancers. Attending #ESMO25? Visit our team - booth 3028, Hall 3.2. Learn more: spkl.io/63328AXBag
October 17, 2025 at 1:00 PM
Explore the latest in research involving Foundation Medicine’s homologous recombination deficiency signature (HRDsig) across key disease areas, including ovarian, lung & gastric cancers. Attending #ESMO25? Visit our team - booth 3028, Hall 3.2. Learn more: spkl.io/63328AXBag
#NewResearch being presented as an oral presentation at #ESMO25 includes a new study aimed at characterizing the demographic and genomic differences between patients with MET+ and MET- papillary renal cell carcinoma. Visit us at booth 3028 in hall 3.2: spkl.io/63323An0Cl
October 16, 2025 at 4:00 PM
#NewResearch being presented as an oral presentation at #ESMO25 includes a new study aimed at characterizing the demographic and genomic differences between patients with MET+ and MET- papillary renal cell carcinoma. Visit us at booth 3028 in hall 3.2: spkl.io/63323An0Cl
Our team is excited to attend #Targets25 in Boston next week! Visit booth 216 to learn more about Foundation Medicine’s high-quality portfolio of precision diagnostic solutions. Scroll through for more about our research being presented. Connect with us: spkl.io/63328AnIH4
October 15, 2025 at 4:00 PM
Our team is excited to attend #Targets25 in Boston next week! Visit booth 216 to learn more about Foundation Medicine’s high-quality portfolio of precision diagnostic solutions. Scroll through for more about our research being presented. Connect with us: spkl.io/63328AnIH4
Foundation Medicine is excited to join the oncology community at #ESMO25! Click to learn more about the research being presented: spkl.io/63324Anb7e
October 13, 2025 at 10:08 PM
Foundation Medicine is excited to join the oncology community at #ESMO25! Click to learn more about the research being presented: spkl.io/63324Anb7e
Visit booth 3028 in Hall 3.2 at #ESMO25 for discussions around the latest advancements in cancer care. Join us for our #BoothTalk series and connect with Foundation Medicine experts on our latest innovations in precision diagnostics: spkl.io/63322ApiAy
October 9, 2025 at 4:00 PM
Visit booth 3028 in Hall 3.2 at #ESMO25 for discussions around the latest advancements in cancer care. Join us for our #BoothTalk series and connect with Foundation Medicine experts on our latest innovations in precision diagnostics: spkl.io/63322ApiAy
Join Foundation Medicine and Precision Medicine Online for an expert presentation on how comprehensive genomic profiling can help provide insights to inform treatment decisions in HR+ HER2- advanced breast cancer. Register for the webinar today: spkl.io/63325Apif9
October 8, 2025 at 4:00 PM
Join Foundation Medicine and Precision Medicine Online for an expert presentation on how comprehensive genomic profiling can help provide insights to inform treatment decisions in HR+ HER2- advanced breast cancer. Register for the webinar today: spkl.io/63325Apif9
#NewPublication in Cancer Research Communications: “Clinical validity of FoundationOne®Liquid CDx for detection of BRAF V600E in colorectal cancer.”: spkl.io/63328ApiFs
*FDA-approved; Rx only; doesn't guarantee treatment match or that all alterations will be found spkl.io/63329ApiFt.
*FDA-approved; Rx only; doesn't guarantee treatment match or that all alterations will be found spkl.io/63329ApiFt.
October 7, 2025 at 4:00 PM
#NewPublication in Cancer Research Communications: “Clinical validity of FoundationOne®Liquid CDx for detection of BRAF V600E in colorectal cancer.”: spkl.io/63328ApiFs
*FDA-approved; Rx only; doesn't guarantee treatment match or that all alterations will be found spkl.io/63329ApiFt.
*FDA-approved; Rx only; doesn't guarantee treatment match or that all alterations will be found spkl.io/63329ApiFt.
Foundation Medicine will be at #ESMO25! Visit us at booth 3028, located in Hall 3.2 to meet with our team. Learn more about our activities at this year’s meeting and schedule a time with us: spkl.io/63322ApSyg
October 6, 2025 at 4:00 PM
Foundation Medicine will be at #ESMO25! Visit us at booth 3028, located in Hall 3.2 to meet with our team. Learn more about our activities at this year’s meeting and schedule a time with us: spkl.io/63322ApSyg
Foundation Medicine is committed to advancing access to high-quality biomarker tests to deliver on the value of precision medicine. We are proud to award our 2025 IDEA Program grant to My Style Matters, Inc. & H.Y.P.E. to Empower, Inc. Learn more: spkl.io/63323ApbPD
October 2, 2025 at 11:03 AM
Foundation Medicine is committed to advancing access to high-quality biomarker tests to deliver on the value of precision medicine. We are proud to award our 2025 IDEA Program grant to My Style Matters, Inc. & H.Y.P.E. to Empower, Inc. Learn more: spkl.io/63323ApbPD
Proud to recognize #BreastCancerAwarenessMonth this October and to help support greater education and information around the disease.
October 1, 2025 at 12:00 PM
Proud to recognize #BreastCancerAwarenessMonth this October and to help support greater education and information around the disease.
Foundation Medicine is proud to support the National Organization for Rare Disorders’ (@nordrare.bsky.social) Rare Cancer Coalition this #RareCancerDay. Let’s raise awareness and stand with the rare cancer community. Learn more: spkl.io/63320ATd3E
September 30, 2025 at 1:00 PM
Foundation Medicine is proud to support the National Organization for Rare Disorders’ (@nordrare.bsky.social) Rare Cancer Coalition this #RareCancerDay. Let’s raise awareness and stand with the rare cancer community. Learn more: spkl.io/63320ATd3E